Mizuho Cuts Acadia Healthcare (NASDAQ:ACHC) Price Target to $70.00

Acadia Healthcare (NASDAQ:ACHC) had its target price lowered by Mizuho from $84.00 to $70.00 in a report issued on Friday morning, Benzinga reports. The brokerage currently has a neutral rating on the stock.

Several other research analysts also recently commented on ACHC. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a sell rating to a hold rating and set a $70.00 target price for the company in a research note on Thursday, April 25th. TheStreet raised shares of Acadia Healthcare from a c rating to a b- rating in a research report on Monday, March 4th. TD Cowen lifted their target price on shares of Acadia Healthcare from $86.00 to $101.00 and gave the stock an outperform rating in a report on Friday, March 1st. UBS Group increased their price target on shares of Acadia Healthcare from $88.00 to $102.00 and gave the company a buy rating in a report on Wednesday, February 28th. Finally, Bank of America decreased their target price on Acadia Healthcare from $105.00 to $90.00 and set a buy rating on the stock in a research report on Thursday. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of Moderate Buy and an average price target of $88.89.

Acadia Healthcare Trading Down 0.9 %

NASDAQ ACHC opened at $66.12 on Friday. Acadia Healthcare has a 12 month low of $64.74 and a 12 month high of $87.77. The company has a current ratio of 1.27, a quick ratio of 0.67 and a debt-to-equity ratio of 0.63. The stock has a 50 day moving average of $76.77 and a 200-day moving average of $77.52. The company has a market cap of $6.11 billion, a PE ratio of -472.25, a PEG ratio of 1.95 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, May 1st. The company reported $0.84 EPS for the quarter, beating analysts’ consensus estimates of $0.80 by $0.04. The firm had revenue of $768.10 million during the quarter, compared to analysts’ expectations of $779.20 million. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. The company’s revenue for the quarter was up 9.1% compared to the same quarter last year. During the same quarter last year, the company posted $0.75 earnings per share. On average, equities research analysts anticipate that Acadia Healthcare will post 3.56 EPS for the current fiscal year.

Insider Activity

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the firm’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the transaction, the director now directly owns 46,074 shares of the company’s stock, valued at approximately $3,934,258.86. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On Acadia Healthcare

Large investors have recently modified their holdings of the business. Fifth Third Bancorp increased its position in Acadia Healthcare by 25.5% during the 4th quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock worth $52,000 after purchasing an additional 136 shares in the last quarter. Estate Counselors LLC grew its stake in shares of Acadia Healthcare by 0.9% during the third quarter. Estate Counselors LLC now owns 16,410 shares of the company’s stock worth $1,154,000 after buying an additional 145 shares during the last quarter. Tranquility Partners LLC increased its holdings in shares of Acadia Healthcare by 5.3% during the fourth quarter. Tranquility Partners LLC now owns 3,395 shares of the company’s stock worth $264,000 after buying an additional 170 shares in the last quarter. Mackenzie Financial Corp lifted its stake in shares of Acadia Healthcare by 1.3% in the 3rd quarter. Mackenzie Financial Corp now owns 15,737 shares of the company’s stock valued at $1,063,000 after acquiring an additional 199 shares during the last quarter. Finally, New York State Teachers Retirement System grew its position in Acadia Healthcare by 0.3% during the 1st quarter. New York State Teachers Retirement System now owns 76,054 shares of the company’s stock worth $6,025,000 after acquiring an additional 200 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.